Regencell Bioscience Holdings Limited (RGC)

NASDAQ: RGC · Real-Time Price · USD

25.80

-1.20 (-4.44%)

At close: May 22, 2026, 4:00 PM EDT

26.50

+0.70 (2.71%)

After-hours: May 22, 2026, 7:57 PM EDT

RGC Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 22, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Cap	12,758	8,426	44	300	450	-
Market Cap Growth	362.45%	19171.44%	-85.42%	-33.41%	-	-
Enterprise Value	12,756	8,421	35.79	288.24	434.21	0
Last Close Price	25.80	17.04	0.09	0.61	0.91	-
PB Ratio	10462.52	1733.67	5.32	24.92	26.38	-
P/TBV Ratio	10462.50	1733.67	5.32	24.92	25.96	-
Debt / Equity Ratio	0.11	0.05	0.00	0.00	0.02	-0.92
Net Debt / Equity Ratio	-1.62	-0.90	-0.96	-0.92	-0.92	-0.91
Net Debt / EBITDA Ratio	0.28	1.29	1.97	2.02	2.23	-2.67
Net Debt / FCF Ratio	0.49	1.33	1.97	2.23	2.59	-4.72
Quick Ratio	1.42	7.38	41.13	19.06	28.41	0.01
Current Ratio	1.42	7.39	41.92	19.15	28.46	0.02
Return on Equity (ROE)	-177.66%	-54.81%	-43.18%	-41.71%	-116.10%	40.51%
Return on Assets (ROA)	-135.96%	-53.12%	-44.98%	-40.95%	-82.99%	-323.45%
Return on Invested Capital (ROIC)	-212.04%	-874.85%	-757.56%	-534.00%	-1315.08%	1061.65%
Return on Capital Employed (ROCE)	-161.61%	-56.54%	-46.76%	-42.60%	-113.33%	41.55%
Buyback Yield / Dilution	-	0.00%	0.00%	-1.62%	-28.06%	0.00%
Total Shareholder Return	-	0.00%	0.00%	-1.62%	-28.06%	0.00%

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q